![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
20
Medigraph Pharmaceuticals Pvt. Ltd. Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from WHO-GMP.
One of their significant offerings is Azathioprine, supported by a 'Expired' Certificate of Suitability (CEP) with the number R0-CEP 2006-282 - Rev 01
This Chemical Type CEP, issued on June 24, 2010, remains in force until March 28, 2013, ensuring its reliability within the pharmaceutical industry.
Substance Number 369 associated with this CEP further emphasizes